Tag: Ramiven
Eli Lilly introduces Ramiven® (abemaciclib) in India, for certain high-risk early...
Abemaciclib is a CDK4/6 inhibitor which has now been approved for HR+ HER2 - node positive high risk early breast cancer.
Explore thousands of colleges and their courses. Enhance your skills with online courses, online internship programs and test series. Know your career alternatives and get latest updates from educational world.
Get high quality filtered student leads, home page ads, top search rank and separate website. We will actively work towards increasing the brand awareness.
Our team is always here to collaborate and address all your doubts.
by proceeding ahead you expressly agree to the EasyShiksha terms of use and privacy policy.